-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Freeline Therapeutics Holdings plc quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2022.
- Freeline Therapeutics Holdings plc Operating Income (Loss) for the quarter ending March 31, 2023 was -$20.1M, a 28.7% increase year-over-year.
- Freeline Therapeutics Holdings plc annual Operating Income (Loss) for 2022 was -$98.4M, a 30.9% increase from 2021.
- Freeline Therapeutics Holdings plc annual Operating Income (Loss) for 2021 was -$142M, a 39% decline from 2020.
- Freeline Therapeutics Holdings plc annual Operating Income (Loss) for 2020 was -$102M, a 61% decline from 2019.
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)